APA (7th ed.) Citation

Jr, F. T., E, A., L, G., AF, D., C, S., S, P., & GJ, M. (2021). Lefamulin efficacy and safety in a pooled phase 3 clinical trial population with community-acquired bacterial pneumonia and common clinical comorbidities. BMC pulmonary medicine, 21(1), 154. https://doi.org/10.1186/s12890-021-01472-z

Chicago Style (17th ed.) Citation

Jr, File TM, Alexander E, Goldberg L, Das AF, Sandrock C, Paukner S, and Moran GJ. "Lefamulin Efficacy and Safety in a Pooled Phase 3 Clinical Trial Population with Community-acquired Bacterial Pneumonia and Common Clinical Comorbidities." BMC Pulmonary Medicine 21, no. 1 (2021): 154. https://doi.org/10.1186/s12890-021-01472-z.

MLA (9th ed.) Citation

Jr, File TM, et al. "Lefamulin Efficacy and Safety in a Pooled Phase 3 Clinical Trial Population with Community-acquired Bacterial Pneumonia and Common Clinical Comorbidities." BMC Pulmonary Medicine, vol. 21, no. 1, 2021, p. 154, https://doi.org/10.1186/s12890-021-01472-z.